NASDAQ · Medical - Devices

TMDX (TMDX) Stock

$82.24 -3.10% NASDAQ: TMDX Healthcare

Valuation

MetricValue
Price$82.24
Market Cap$2.84B
P/E Ratio19.06
P/B Ratio5.62
P/S Ratio4.36
EPS (TTM)$4.87
52-Week High$156.00
52-Week Low$60.10
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE32.97%
ROA10.36%
ROCE5.97%
Gross Margin59.09%
Operating Margin14.85%
Net Margin22.69%
Debt/Equity1.67
Current Ratio7.17

Annual Financials (USD)

Metric20212022202320242025
Revenue$30.0M$93.0M$242.0M$442.0M$605.0M
Operating Profit$-39.0M$-31.0M$-29.0M$37.0M$109.0M
Net Profit$-44.0M$-36.0M$-25.0M$35.0M$190.0M
EPS$-1.60$-1.23$-0.77$1.01$4.87
Op Margin-130.3%-33.6%-11.9%8.5%17.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$135.0M$277.0M$706.0M$804.0M$1.1B
Total Liabilities$67.0M$90.0M$569.0M$575.0M$595.0M
Cash$26.0M$201.0M$395.0M$337.0M$488.0M
Borrowings$44.0M$68.0M$516.0M$518.0M$470.0M

Latest News

TMDX: Raising target price to $71.00 Argus Research · Jul 15, 2026 Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut? Insider Monkey · Jul 8, 2026 TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH PR Newswire · Jul 6, 2026 Where Will TransMedics Group Stock Be in 10 Years? Motley Fool · Jul 3, 2026 3 Growth Stocks to Buy on the Dip Motley Fool · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-29.0M$-46.0M$-13.0M$49.0M$193.0M
Investing Cash Flow$26.0M$43.0M$-373.0M$-259.0M$-119.0M
Financing Cash Flow$0$6.0M$-52.0M$0$17.0M
Net Cash Flow$1.0M$176.0M$194.0M$-58.0M$152.0M
Free Cash Flow$-32.0M$-58.0M$-192.0M$-81.0M$134.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.18
EV / EBITDA27.56
FCF Yield2.71%
Quick Ratio6.07
Interest Coverage3.84
Return 1Y-32.58%
Return 3Y-21.42%
Return 5Y140.54%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AKROAkero Therapeutics, Inc. $54.65 +0.00% -19.87 $4.50B 0.00%
BRKR $56.03 -3.41% 23.24 $8.53B 0.35%
GKOS $176.70 -1.59% -42.65 $10.42B 0.00%
HNGE $90.02 -2.74% -13.65 $6.97B 0.00%
IMVT $39.90 -2.25% -14.48 $8.24B 0.00%

About TMDX

TMDX stock trades at $82.24 with a market capitalization of $2.84B. The stock is valued at a price-to-earnings (P/E) ratio of 19.06, price-to-book of 5.62, price-to-sales of 4.36. Over the past 52 weeks the stock has ranged between $60.10 and $156.00, and currently trades 47.3% below its 52-week high.

On profitability, TMDX generates a return on equity (ROE) of 32.97% — well above the market average, a sign of a high-quality business, return on capital employed of 5.97%, an operating margin of 14.85%, a net profit margin of 22.69%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides